Publications
5674 Results
- Journal / Conference
- Blood 126(23):342; American Society of Hematology Annual Meeting (Dec 5-8, Orlando, FL), oral;
- Year
- 2015
- Research Committee(s)
- Lymphoma
- Study Number(s)
- CTSU/9177
Risk-adapted low-intensity therapy in adults with Burkitt lymphoma: preliminary report of a multicenter prospective phase II study of DA-EPOCH-R
- Journal / Conference
- Blood 2015 126(23):2678; American Society of Hematology Annual Meeting (Dec 5-8, Orlando, FL), poster presentation;
- Year
- 2015
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0016
Genomic alterations important for the prognosis in patients with follicular lymphoma treated on SWOG Study S0016
- Journal / Conference
- Blood 126(23):1498; American Society of Hematology Annual Meeting (Dec 5-8, Orlando, FL), poster;
- Year
- 2015
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0816
Feasibility of interim PET-adapted therapy in HIV-positive patients with advanced Hodgkin Lymphoma (HL) – sub-analysis of SWOG S0816 phase 2 trial
- Journal / Conference
- Breast Cancer Research and Treatment Apr;150(3):605-611
- Year
- 2015
- Research Committee(s)
- Breast
- PMID
- PMID25833209
- PMC
- PMC Pending
Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer
- Journal / Conference
- Leukemia & Lymphoma Nov;56(11):3031-3027
- Year
- 2015
- Research Committee(s)
- Leukemia
- PMID
- PMID25721902
- PMC
- PMC4688910
- Study Number(s)
- E2997
Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997
- Journal / Conference
- Journal of Thoracic Oncology Volume 10, Number 9, Supplement 2, September 2015; World Conference on Lung Cancer (WCLC), (September 6-9, 2015, Denver, CO), oral
- Year
- 2015
- Research Committee(s)
- Lung
- Study Number(s)
- S0819
A randomized, phase III study comparing carboplatin/paclitaxel or carboplatin/ paclitaxel/bevacizumab with or without concurrent cetuximab in patients with advanced non-small cell lung cancer (NSCLC): SWOG S0819
- Journal / Conference
- Clinical Cancer Research May 15;21(10):2236-2243
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID25979930
- PMC
- PMC4862209
- Study Number(s)
- S1400
Squamous cell lung cancer: from tumor genomics to cancer therapeutics
- Journal / Conference
- Clinical Cancer Research May 15;21(10):2213-2220
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID25979927
- PMC
- PMC4505624
- Study Number(s)
- S1400
Lung cancer in the era of precision medicine
- Journal / Conference
- Lancet Oncology Aug;16(8):872-873
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID26156654
- PMC
- Commentary not within scope of Public Access Policy
- Study Number(s)
- S1400
EGFR tyrosine kinase inhibitors in squamous cell lung cancer
- Journal / Conference
- Journal of Clinical Oncology Sep 10;33(26):2839-2840
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID26215942
- PMC
- editorial not within scope of Public Access Policy
- Study Number(s)
- S1403